Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
5.67
+0.13 (2.35%)
At close: Feb 21, 2025, 4:00 PM
5.77
+0.10 (1.76%)
After-hours: Feb 21, 2025, 5:20 PM EST
Phathom Pharmaceuticals Employees
Phathom Pharmaceuticals had 452 employees as of December 31, 2023. The number of employees increased by 340 or 303.57% compared to the previous year.
Employees
452
Change (1Y)
340
Growth (1Y)
303.57%
Revenue / Employee
$58,119
Profits / Employee
-$750,985
Market Cap
387.70M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 452 | 340 | 303.57% |
| Dec 31, 2022 | 112 | 35 | 45.45% |
| Dec 31, 2021 | 77 | 22 | 40.00% |
| Dec 31, 2020 | 55 | 30 | 120.00% |
| Dec 31, 2019 | 25 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
PHAT News
- 24 days ago - Phathom Pharmaceuticals to Present at the Guggenheim Securities SMID Cap Biotech Conference - GlobeNewsWire
- 2 months ago - Phathom Pharmaceuticals Submits Citizen Petition to FDA Seeking Correction of Orange Book Listings for VOQUEZNA® (vonoprazan) Tablets - GlobeNewsWire
- 3 months ago - Phathom Pharmaceuticals, Inc. (PHAT) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024 - GlobeNewsWire
- 4 months ago - Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual Meeting - GlobeNewsWire
- 6 months ago - Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 7 months ago - Phathom Pharmaceuticals, Inc. (PHAT) Q2 2024 Earnings Call Transcript - Seeking Alpha